ID: ALA3356107

Max Phase: Preclinical

Molecular Formula: C28H20F3N3

Molecular Weight: 455.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  FC(F)(F)c1ccccc1-c1nc(NCc2ccc(-c3ccccc3)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C28H20F3N3/c29-28(30,31)24-12-6-4-10-22(24)27-33-25-13-7-5-11-23(25)26(34-27)32-18-19-14-16-21(17-15-19)20-8-2-1-3-9-20/h1-17H,18H2,(H,32,33,34)

Standard InChI Key:  SQHRNXZOQSGESZ-UHFFFAOYSA-N

Associated Targets(Human)

Ubiquitin carboxyl-terminal hydrolase 1/WD repeat-containing protein 48 106 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 455.48Molecular Weight (Monoisotopic): 455.1609AlogP: 7.59#Rotatable Bonds: 5
Polar Surface Area: 37.81Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.40CX LogP: 8.23CX LogD: 8.23
Aromatic Rings: 5Heavy Atoms: 34QED Weighted: 0.30Np Likeness Score: -1.09

References

1. Dexheimer TS, Rosenthal AS, Luci DK, Liang Q, Villamil MA, Chen J, Sun H, Kerns EH, Simeonov A, Jadhav A, Zhuang Z, Maloney DJ..  (2014)  Synthesis and structure-activity relationship studies of N-benzyl-2-phenylpyrimidin-4-amine derivatives as potent USP1/UAF1 deubiquitinase inhibitors with anticancer activity against nonsmall cell lung cancer.,  57  (19): [PMID:25229643] [10.1021/jm5010495]

Source